272 related articles for article (PubMed ID: 37915324)
1. Philadelphia chromosome-negative myeloproliferative chronic neoplasms: is clonal hematopoiesis the main determinant of autoimmune and cardio-vascular manifestations?
Fulvio G; Baldini C; Mosca M; di Paolo A; Bocci G; Palumbo GA; Cacciola E; Migliorini P; Cacciola R; Galimberti S
Front Med (Lausanne); 2023; 10():1254868. PubMed ID: 37915324
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of CHIP-Related Mutation and Risk of Cardio-Cerebrovasculars Events in Patients with Myeloproliferative Neoplasms].
Han X; Bai BB; Feng CC; Zhao S; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):190-196. PubMed ID: 38387920
[TBL] [Abstract][Full Text] [Related]
3. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
[TBL] [Abstract][Full Text] [Related]
4. Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia.
Sasaki K; Kanagal-Shamanna R; Montalban-Bravo G; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Patel K; Soltysiak KA; Cortes J; Kantarjian HM; Garcia-Manero G
Cancer; 2020 Feb; 126(4):765-774. PubMed ID: 31742675
[TBL] [Abstract][Full Text] [Related]
5. Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer.
Barbui T; Gavazzi A; Sciatti E; Finazzi MC; Ghirardi A; Carioli G; Carobbio A
Curr Hematol Malig Rep; 2023 Aug; 18(4):105-112. PubMed ID: 37221411
[TBL] [Abstract][Full Text] [Related]
6. TET2, DNMT3A, IDH1, and JAK2 Mutation in Myeloproliferative Neoplasms in southern Iran.
Abedi E; Ramzi M; Karimi M; Yaghobi R; Mohammadi H; Bayat E; Moghadam M; Farokhian F; Dehghani M; Golafshan HA; Haghpanah S
Int J Organ Transplant Med; 2021; 12(3):12-20. PubMed ID: 35509721
[TBL] [Abstract][Full Text] [Related]
7. Age-related macular degeneration and myeloproliferative neoplasms - A common pathway.
Liisborg C
Acta Ophthalmol; 2022 Oct; 100 Suppl 271(Suppl 271):3-35. PubMed ID: 36200281
[TBL] [Abstract][Full Text] [Related]
8. Clinical consequences of clonal hematopoiesis of indeterminate potential.
Steensma DP
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):264-269. PubMed ID: 30504320
[TBL] [Abstract][Full Text] [Related]
9. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
10. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
Singh I; Singh A
Curr Oncol Rep; 2023 Jun; 25(6):539-547. PubMed ID: 36928826
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasms.
Kameda T; Shide K; Yamaji T; Kamiunten A; Sekine M; Hidaka T; Kubuki Y; Sashida G; Aoyama K; Yoshimitsu M; Abe H; Miike T; Iwakiri H; Tahara Y; Yamamoto S; Hasuike S; Nagata K; Iwama A; Kitanaka A; Shimoda K
Genom Data; 2015 Jun; 4():102-8. PubMed ID: 26484191
[TBL] [Abstract][Full Text] [Related]
12. Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation.
Mas-Peiro S; Hoffmann J; Fichtlscherer S; Dorsheimer L; Rieger MA; Dimmeler S; Vasa-Nicotera M; Zeiher AM
Eur Heart J; 2020 Feb; 41(8):933-939. PubMed ID: 31504400
[TBL] [Abstract][Full Text] [Related]
13. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
Marnell CS; Bick A; Natarajan P
J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Disease in Myeloproliferative Neoplasms:
Leiva O; Hobbs G; Ravid K; Libby P
JACC CardioOncol; 2022 Jun; 4(2):166-182. PubMed ID: 35818539
[TBL] [Abstract][Full Text] [Related]
15. Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms.
Kjær L
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32731609
[TBL] [Abstract][Full Text] [Related]
16. Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms.
Wolach O; Sellar RS; Martinod K; Cherpokova D; McConkey M; Chappell RJ; Silver AJ; Adams D; Castellano CA; Schneider RK; Padera RF; DeAngelo DJ; Wadleigh M; Steensma DP; Galinsky I; Stone RM; Genovese G; McCarroll SA; Iliadou B; Hultman C; Neuberg D; Mullally A; Wagner DD; Ebert BL
Sci Transl Med; 2018 Apr; 10(436):. PubMed ID: 29643232
[TBL] [Abstract][Full Text] [Related]
17. Functional Consequences of Mutations in Myeloproliferative Neoplasms.
Constantinescu SN; Vainchenker W; Levy G; Papadopoulos N
Hemasphere; 2021 Jun; 5(6):e578. PubMed ID: 34095761
[TBL] [Abstract][Full Text] [Related]
18. Clinical consequences of clonal hematopoiesis of indeterminate potential.
Steensma DP
Blood Adv; 2018 Nov; 2(22):3404-3410. PubMed ID: 30482770
[TBL] [Abstract][Full Text] [Related]
19. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
[TBL] [Abstract][Full Text] [Related]
20. Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease.
Cobo I; Tanaka T; Glass CK; Yeang C
Curr Opin Hematol; 2022 Jan; 29(1):1-7. PubMed ID: 34654019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
